|

Multiple Sclerosis Clinical Trials in California

43 recruiting studies across 7 cities

Browse by City

San Francisco
24 trials
San Jose
23 trials
Long Beach
16 trials
Los Angeles
16 trials
San Diego
11 trials
Sacramento
2 trials
Fresno
1 trial

All Trials in California

Phase
Trial Phase Dist.
Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple SclerosisPhase 3<1 mi
Study of COYA 302 for the Treatment of ALSPhase 2<1 mi
TSC Biosample Repository and Natural History Database—<1 mi
Effect of a Fasting Mimicking Diet on Patients With Multiple Sclerosis (FMDMS)N/A<1 mi
MS-ResearchBiomarkerS—<1 mi
Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention StudyPhase 2<1 mi
Central Vein Sign in Multiple Sclerosis Extension StudyN/A<1 mi
Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cutaneous Systemic SclerosisPhase 2<1 mi
Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple SclerosisPhase 3<1 mi
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable CancerPhase 1<1 mi
PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALSPhase 2<1 mi
Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy VolunteersPhase 1/2<1 mi
Concentration of Ofatumumab in the Breast Milk of Lactating Women With Relapsing Forms of Multiple SclerosisPhase 4<1 mi
Pregnancy Registry, Infants, Serum/Milk Analysis (PRISMA)—<1 mi
Effects of Ocrelizumab Treatment on Immune Cells in Lymph Nodes in Multiple SclerosisPhase 4<1 mi
"Selfie" Videos: A Novel, Patient-centered, Comprehensive Approach to Measuring Function in MS—<1 mi
Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair TherapyPhase 1/2<1 mi
A Study Evaluating the Presence and Concentration of BRIUMVI™ (Ublituximab) in Breast Milk—<1 mi
Care in Multiple Sclerosis (MS)—<1 mi
Neuroprotection With N-acetyl Cysteine for Patients With Progressive Multiple SclerosisPhase 2<1 mi
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)Phase 2<1 mi
ECoG BMI for Motor and Speech ControlN/A<1 mi
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical IllnessesPhase 2<1 mi
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)—1 mi
Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple SclerosisPhase 37 mi
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple SclerosisPhase 37 mi
Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE)Phase 211 mi
A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune DisordersPhase 111 mi
AMX0114 in Adult Participants With Amyotrophic Lateral SclerosisPhase 111 mi
Post-Authorization Safety Study for Assessment of Pregnancy Outcomes in Patients Treated With Mayzent—11 mi
Kesimpta (Ofatumumab) Pregnancy Registry—11 mi
A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease—14 mi
AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe EpilepsyPhase 1/216 mi
A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell ( CAR-T) Therapy in Subjects With Non-relapsing and Progressive Forms of Multiple SclerosisPhase 116 mi
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)Phase 316 mi
A Study of AZD0120 in Autoimmune DiseasesPhase 117 mi
A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and Subcutaneous RO7121932 Administration in Participants With Multiple SclerosisPhase 117 mi
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple SclerosisPhase 317 mi
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of UblituximabPhase 320 mi
A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)Phase 122 mi
A Study to Assess Bioequivalence of Two Subcutaneous (SC) Formulations of Ocrelizumab in Participants With Multiple Sclerosis (MS)Phase 233 mi
Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)Phase 333 mi
Entire-body PET Scans for Multiple SclerosisEarly 135 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.